Unlocking the potential of value-based health care by defining global standard sets of outcome measures that matter to patients with cardiovascular diseases.


Journal

European heart journal. Quality of care & clinical outcomes
ISSN: 2058-1742
Titre abrégé: Eur Heart J Qual Care Clin Outcomes
Pays: England
ID NLM: 101677796

Informations de publication

Date de publication:
01 04 2019
Historique:
received: 28 09 2018
revised: 29 11 2018
accepted: 01 12 2018
pubmed: 6 12 2018
medline: 22 5 2019
entrez: 6 12 2018
Statut: ppublish

Résumé

As health systems around the world increasingly look to record and improve the value of care that they provide to patients, being able to measure the outcomes that matter most to patients is vital. Clinicians today gather more data than ever before, but what is measured often has little relationship to the results of care that matter most to patients. Through its working groups of global experts in particular diseases, the International Consortium for Health Outcomes Measurement aims to define minimum Standard Sets of outcomes, along with case-mix factors to support risk adjustment and meaningful comparison. These Standard Sets may then be implemented globally empowering patients to select providers with the best outcomes at the lowest cost, empowering providers that deliver superior outcomes at competitive costs to excel, and empowering payers to negotiate contracts based on results. The International Consortium for Health Outcomes Measurement has published 24 Standard Sets including coronary artery disease, heart failure, hypertension, and stroke and is nearing the completion of its work in atrial fibrillation.

Identifiants

pubmed: 30517621
pii: 5230000
doi: 10.1093/ehjqcco/qcy056
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

92-95

Informations de copyright

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2018. For permissions, please email: journals.permissions@oup.com.

Auteurs

William H Seligman (WH)

International Consortium for Health Outcomes Measurement, Hamilton House, 4 Mabledon Place, London, UK.

Matthew Salt (M)

International Consortium for Health Outcomes Measurement, Hamilton House, 4 Mabledon Place, London, UK.

Alethse De la Torre Rosas (A)

International Consortium for Health Outcomes Measurement, Hamilton House, 4 Mabledon Place, London, UK.

Zofia Das-Gupta (Z)

International Consortium for Health Outcomes Measurement, Hamilton House, 4 Mabledon Place, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH